Top Markets
Coin of the day
Ever Supreme Bio Technology Co., Ltd Ever Supreme Bio Technology Co., Ltd

Ever Supreme Bio Technology Co., Ltd

6712
Pozycja w akcjach #13229
This enterprise is dedicated to the investigation, advancement, and creation of... This enterprise is dedicated to the investigation, advancement, and creation of pharmaceutical treatments leveraging human mesenchymal stem cells and immune cells. Its current portfolio features UMC01, a drug candidate undergoing Phase I clinical evaluation for addressing conditions such as myocardial infarction and stroke. Additionally, ADCV01 is progressing through Phase II clinical trials as a potential therapy for aggressive brain tumors. The company also develops CAR001, an innovative chimeric antigen receptor immune cell product, alongside bone-marrow stem cells (BMSC) used in managing chronic stroke, severe osteoarthritis, and spinal cord injuries. Established in 2016, the firm operates from its headquarters in Taichung, Taiwan.
Cena akcji
$4.99
Kapitalizacja rynkowa
$508.03M
Zmiana (1 dzień)
-2.48%
Zmiana (1 rok)
2.10%
Kraj
TW
Handel Ever Supreme Bio Technology Co., Ltd (6712)

Kategoria

Historia ceny akcji dla Ever Supreme Bio Technology Co., Ltd (6712)
Najwyższa cena zamknięcia: $4.88 dnia 2026-08-01

Najniższa cena zamknięcia: $1.98 dnia 2018-10-01
Historia cen akcji firmy Ever Supreme Bio Technology Co., Ltd od 2018 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -4.84%
2025 8.48%
2024 -5.27%
2023 0.33%
2022 -5.52%
2021 21.39%
2020 20.06%
2019 82.02%
2018 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$541.28 38.43%
US
$1.02K 43.57%
NL
$121.01 -13.08%
AU
$142.23 490.41%
US
$749.90 5.87%
CH